AAAAAA
Results:
1-14
|
Results: 14
Authors:
Bos, AME
de Vries, EGE
Dombernovsky, P
Aamdal, S
Uges, DRA
Schrijvers, D
Wanders, J
Roelvink, MWJ
Hanauske, AR
Bortini, S
Capriati, A
Crea, AEG
Vermorken, JB
Citation: Ame. Bos et al., Pharmacokinetics of MEN-10755, a novel anthracycline disaccharide analogue, in two phase I studies in adults with advanced solid tumours, CANC CHEMOT, 48(5), 2001, pp. 361-369
Authors:
Van den Eynden, B
Hermann, I
Schrijvers, D
Van Royen, P
Maes, R
Vermeulen, L
Herweyers, K
Smits, W
Verhoeven, A
Clara, R
Denekens, J
Citation: B. Van Den Eynden et al., Factors determining the place of palliative care and death of cancer patients, SUPP CARE C, 8(1), 2000, pp. 59-64
Authors:
Schrijvers, D
Pronk, L
Highley, M
Bruno, R
Locci-Tonelli, D
De Bruijn, E
Van Oosterom, AT
Verweij, J
Citation: D. Schrijvers et al., Pharmacokinetics of ifosfamide are changed by combination with docetaxel -Results of a phase I pharmacologic study, AM J CL ONC, 23(4), 2000, pp. 358-363
Authors:
Mentens, Y
Schrijvers, D
Van den Brande, J
Van Schil, P
Vermorken, JB
Citation: Y. Mentens et al., Thoracic wall prosthesis prevents deep invasion by non-small-cell lung cancer, AM J CL ONC, 23(1), 2000, pp. 32-33
Authors:
Damen, J
Schrijvers, D
Van den Brande, J
Pelgrims, J
Vermorken, J
Citation: J. Damen et al., Intraperitoneal treatment of peritoneo-venous shunt infection in a cancer patient, SC J IN DIS, 32(1), 2000, pp. 106-106
Authors:
Schrijvers, D
Van den Brande, J
Vermorken, JB
Citation: D. Schrijvers et al., Supravenous discoloration of the skin due to docetaxel treatment, BR J DERM, 142(5), 2000, pp. 1069-1070
Authors:
Pelgrims, J
De Vos, F
Van den Brande, J
Schrijvers, D
Prove, A
Vermorken, JB
Citation: J. Pelgrims et al., Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature, BR J CANC, 82(2), 2000, pp. 291-294
Authors:
Schrijvers, D
Catimel, G
Highley, M
Hoppener, FJP
Dirix, L
De Bruijn, E
Droz, JP
Van Oosterom, AT
Citation: D. Schrijvers et al., KW-2149-induced pulmonary toxicity is not prevented by corticosteroids: a phase I and pharmacokinetic study, ANTI-CANC D, 10(7), 1999, pp. 633-639
Authors:
Schrijvers, D
Highley, R
De Bruyn, E
Van Oosterom, AT
Vermorken, JB
Citation: D. Schrijvers et al., Role of red blood cells in pharmacokinetics of chemotherapeutic agents, ANTI-CANC D, 10(2), 1999, pp. 147-153
Authors:
Van den Brande, J
Schrijvers, D
Colpaert, C
Vermorken, JB
Citation: J. Van Den Brande et al., Cytomegalovirus colitis after administration of docetaxel-5-fluorouracil-cisplatin chemotherapy for locally advanced hypopharyngeal cancer, ANN ONCOL, 10(11), 1999, pp. 1369-1372
Authors:
Schoffski, P
Catimel, G
Planting, AST
Droz, JP
Verweij, J
Schrijvers, D
Gras, L
Schrijvers, A
Wanders, J
Hanauske, AR
Citation: P. Schoffski et al., Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck - Results of a phase II study of the EORTC Early Clinical Studies Group, ANN ONCOL, 10(1), 1999, pp. 119-122
Authors:
Hendriks, JMH
Van Schil, PEY
Schrijvers, D
Citation: Jmh. Hendriks et al., Bilateral pulmonary resection for lung metastases: report of two cases, EUR J SUR O, 25(5), 1999, pp. 552-553
Authors:
Hendriks, JMH
Van Schil, PEY
Schrijvers, D
Van Marck, E
Eyskens, E
Citation: Jmh. Hendriks et al., Rebound thymic hyperplasia after chemotherapy in a patient treated for pulmonary metastases, ACT CHIR B, 99(6), 1999, pp. 312-314
Authors:
Schrijvers, D
Tai-Apin, C
De Smet, MC
Cornil, P
Vermorken, JB
Bruyneel, P
Citation: D. Schrijvers et al., Determination of compatibility and stability of drugs used in palliative care, J CLIN PH T, 23(4), 1998, pp. 311-314
Risultati:
1-14
|